Chula Vista, CA, United States of America

Sean Sigarlaki


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sean Sigarlaki: Innovator in Optical Technology

Introduction

Sean Sigarlaki is a notable inventor based in Chula Vista, California. He has made significant contributions to the field of optical technology, particularly in the design and manufacturing of lenses. With a total of 2 patents to his name, Sigarlaki's work focuses on improving visual clarity through innovative lens solutions.

Latest Patents

One of Sean Sigarlaki's latest patents is titled "Methods and Lenses for Correction of Chromatic Aberration." This invention provides lenses and methods for designing and manufacturing these lenses with reduced chromatic aberration. The lenses are specifically designed to correct chromatic aberration that occurs as multichromatic light passes through them. This advancement is crucial for enhancing the quality of optical devices.

Career Highlights

Throughout his career, Sean Sigarlaki has worked with prominent companies in the optical industry. He has been associated with Ophthonix, Inc. and Essilor International, which is also known as Compagnie Generale D'optique. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in lens technology.

Collaborations

Sean has collaborated with esteemed professionals in his field, including Lawrence H. Sverdrup and Jagdish M. Jethmalani. These collaborations have further enriched his work and have led to innovative solutions in optical design.

Conclusion

Sean Sigarlaki's contributions to the field of optical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in lens design and manufacturing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…